At a Glance
AI-generatedGuided Therapeutics posted material revenue growth in fiscal 2025, alongside wider operating losses and disclosed going concern risks.
8-K
On March 2, 2026, Guided Therapeutics, Inc. completed a Warrant Exchange of certain Eligible Warrants from its September 1, 2022 Private Offering, issuing 4,825,000 shares of restricted Common Stock and receiving $980,000 in cash proceeds. This increased outstanding Common Stock from 86,691,976 to 91,516,976 shares, with 16,398,080 Eligible Warrants remaining outstanding.—
Market Cap
—
Revenue
—
Net Income
Employees4
Fundamentals
How The Business Makes Money
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.
Industry Medical - Devices
Activity
Analyst View
Company Profile
CIK0000924515
ISINUS40171F5017
CUSIP40171F501
Phone770 242 8723
Address5835 Peachtree Corners East, Norcross, GA, 30092, US
SEC EDGAR